Common Contracts
3 similar Note Purchase Agreement contracts by Marina Biotech, Inc., Mateon Therapeutics Inc, Oncotelic Therapeutics, Inc.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 5th, 2021 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • California
THIS NOTE PURCHASE AGREEMENT (“Agreement”) is made as of August 4, 2021 by and among Oncotelic Therapeutics, Inc., a Delaware corporation (f/k/a Mateon Therapeutics, Inc. and now the “Company”), and the lender (each individually a “Lender,” and collectively the “Lenders”) named on the Schedule of Lenders attached hereto (the “Schedule of Lenders”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Notes (as defined below).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • November 25th, 2019 • Mateon Therapeutics Inc • Pharmaceutical preparations • New York
THIS NOTE PURCHASE AGREEMENT (“Agreement”) is made as of November 23, 2019 by and among Mateon Therapeutics, Inc., a Delaware corporation (the “Company”), and the lenders (each individually a “Lender,” and collectively the “Lenders”) named on the Schedule of Lenders attached hereto (the “Schedule of Lenders”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Notes (as defined below).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • June 7th, 2017 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
THIS NOTE PURCHASE AGREEMENT (“Agreement”) is made as of June 1, 2017 by and among Marina Biotech, Inc., a Delaware corporation (the “Company”), and the lenders (each individually a “Lender,” and collectively the “Lenders”) named on the Schedule of Lenders attached hereto (the “Schedule of Lenders”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Notes (as defined below).
